The DOI matches its Crossref record.
Galactosylated chitosan-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery
Abstract
Targeted drug delivery to colon cancer cells can significantly enhance the therapeutic efficiency. Herein, we developed 5-fluorouracil (5-FU)-loaded amino-functionalized mesoporous silica nanoparticle (MSN-NH 2 )-based galactosylated chitosans (GCs), which are galactose receptor-mediated materials for colon-specific drug delivery systems. Both unmodified and functionalized nanoparticles were characterized by scanning electron microscopy, transmission electron microscopy, X-ray diffraction, Fourier transform infrared spectroscopy, nitrogen sorption and dynamic light scattering. Drug loading capacity and drug release properties were determined by ultraviolet spectrophotometry. 5-FU@MSN-NH 2 /GC showed high loading capacity and possessed much higher cytotoxicity on human colon cancer cells (SW620 cells) than 5-FU@MSN-NH 2 and free 5-FU. But, MSN-NH 2 /GC did not show significant cytotoxicity. Subsequently, 5-FU@MSN-NH 2 /GC anti-cancer activity on SW620 cells in vitro was confirmed by cell apoptosis. These results are consistent with the cellular uptake test in which MSN-NH 2 /GC could specifically recognize and bind to cancer cells by the galectin-receptor recognition. But, it is found that pre-addition of galactose in the medium, leading to competitive binding to the galectin receptor of SW620 cells, resulted in a decrease in the binding of MSN-NH 2 /GC to the galectin receptor. The results demonstrated the inorganic–organic nanocomposite could be used as a promising drug delivery carrier for the targeted delivery of drug into galectin-positive colon cancer cells to improve therapeutic index while reducing side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures












Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Carbohydrate-mediated targeting was further demonstrated in galactosylated CS-functionalized MSNPs, which achieved selective cytotoxicity toward HT-29 colon cancer cells via ASGPR recognition, while exhibiting reduced toxicity toward normal fibroblasts [71].”
From Chitosan-Based Drug Delivery Systems for Targeted Chemotherapy in Colorectal Cancer: A Scoping Review (2025) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 57
- Chen WQ, 2018, Report of cancer incidence and mortality in China, 2014, Zhonghua zhong liu za zhi [Chin. J. Oncol.], 40, 5
- 10.1016/j.ijpharm.2016.09.076 · DOI · Paper page
- 10.1039/C6RA18034E · DOI
- 10.1097/00000421-198808000-00010 · DOI
- You Y, 2015, Differential effects of polymer-surface decoration on drug delivery, cellular retention, and action mechanisms of functionalized mesoporous silica nanoparticles, Chem. Asian J., 10, 2743
- 10.1039/C7RA01028A · DOI
- 10.1039/C7RA00899F · DOI
- 10.1016/j.colsurfb.2016.10.049 · DOI
- 10.1002/smll.201602580 · DOI
- 10.2217/nnm-2017-0028 · DOI
- 10.1016/j.eurpolymj.2017.06.033 · DOI
- 10.1016/j.micromeso.2016.09.024 · DOI
- 10.1021/acsami.6b09772 · DOI
- 10.1002/chem.201301081 · DOI
- 10.1016/j.micromeso.2014.08.033 · DOI
- 10.1016/j.colsurfb.2013.05.019 · DOI
- 10.1002/ppsc.201300164 · DOI
- 10.1039/c3tb20415d · DOI
- 10.1039/C5NR03527A · DOI
- 10.1016/j.jcis.2014.12.053 · DOI
- 10.1016/j.carbpol.2014.11.046 · DOI
- 10.1007/s10856-008-3620-1 · DOI
- 10.1016/j.colsurfb.2008.12.018 · DOI
- 10.1007/s11802-017-3253-4 · DOI
- 10.1016/j.carbpol.2013.01.014 · DOI
- 10.1016/j.jconrel.2015.02.022 · DOI
- 10.1016/j.biomaterials.2013.01.079 · DOI
- 10.1136/gut.2009.184556 · DOI
- Barondes SH, 1994, Galectins. Structure and function of a large family of animal lectins, J. Biol. Chem., 269, 20 807, 10.1016/S0021-9258(17)31891-4 · DOI
- 10.1016/j.humpath.2016.02.016 · DOI
- 10.1002/ijc.25945 · DOI
- 10.1016/j.micromeso.2016.04.029 · DOI
- 10.1016/j.jcis.2016.06.043 · DOI
- 10.2147/IJN.S148438 · DOI
- 10.1155/2016/1325174 · DOI
- 10.1016/j.biomaterials.2017.07.030 · DOI
- 10.1016/j.bbagen.2014.06.004 · DOI · Paper page
- 10.1016/j.ejpb.2014.04.017 · DOI
- 10.3390/nano6070126 · DOI
- 10.1021/nn403617j · DOI
- 10.1039/C6RA23182A · DOI
- 10.1039/C4AY01203H · DOI
- 10.2147/IJN.S75098 · DOI
- 10.1088/1757-899X/275/1/012009 · DOI
- 10.1016/j.colsurfb.2017.03.024 · DOI
- 10.1002/anie.200900880 · DOI
- 10.1007/s10934-017-0361-x · DOI
- 10.1021/ja910846q · DOI
- 10.1016/j.carbpol.2017.11.031 · DOI
- 10.1039/C4TB00808A · DOI
- 10.1016/j.ejpb.2004.03.006 · DOI
- 10.1016/j.ijpharm.2012.01.025 · DOI
- 10.1016/j.micromeso.2011.07.023 · DOI
- Dash S, 2010, Kinetic modeling on drug release from controlled drug delivery systems, Acta Pol. Pharm., 67, 217
- 10.1021/nn3044066 · DOI
- 10.1016/j.ejps.2015.12.014 · DOI
- 10.1021/bi00232a015 · DOI
Cited by
Sorted by citations
Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment
Choukaife, H., Seyam, S., Alallam, B., Doolaanea, A. A., & Alfatama, M. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s375229 · Cited by 127
Piotrowska, U., Szatko, J., Nowakowska, A., Klimaszewska, E., Ogorzałek, M., & Sobczak, M. (2025) · Marine Drugs · doi:10.3390/md23120467 · Cited by 14
Metadata
- Authors
- Liu, W., Zhu, Y., Wang, F., Li, X., Liu, X., Pang, J., & Pan, W.
- Affiliations
- Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, People's Republic of China
- Department of Pharmaceutics, School of Pharmacy, Zhengzhou University, 100 Science Avenue, Zhengzhou 450001, People's Republic of China
- Venue
- Royal Society Open Science
- Publisher
- The Royal Society
- Published
- 2018-12
- Volume
- 5
- Issue
- 12
- Pages
- 181027
- ISSN
- 2054-5703
- PMC
- PMC6304116
- Cited by
- 59
- References
- 0
- Language
- en
- Funders
- Zhengzhou University
- National Natural Science Foundation of China (81473163)
- Shenyang Pharmaceutical University
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review